Federico Grossi - 01 Aug 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol
APLS
Transactions as of
01 Aug 2022
Net transactions value
-$139,975
Form type
4
Filing time
02 Aug 2022, 16:18:17 UTC
Previous filing
02 Jun 2022
Next filing
02 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $139,975 -2,500 -2.3% $55.99 107,384 01 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10b5-1 trading plan.
F2 Includes 323 shares from 4/30/2022 ESPP purchase.